Tuesday, November 3, 2026
Form 4 reports shares bought or sold by company insiders such as officers, directors or large holders.
Thursday, October 29, 2026
This is a public filing with the U.S. Securities and Exchange Commission.
Monday, October 26, 2026
Bambusa Therapeutics Files Prospectus for Initial Public Offering
Bambusa Therapeutics submitted a prospectus covering a stock market listing. The document allows for the sale of as many as 9.375 million shares.
Frequently asked questions
What is the latest news on BBTX?
Nov 3, 2026: Bambusa Therapeutics, Inc. filed an insider trading report (Form 4) (SEC) · Oct 29, 2026: Bambusa Therapeutics, Inc. filed Form S-1MEF with the SEC (SEC) · Oct 26, 2026: Bambusa Therapeutics Files Prospectus for Initial Public Offering (Benzinga)
What has BBTX filed with the SEC recently?
Nov 3, 2026: Bambusa Therapeutics, Inc. filed an insider trading report (Form 4) · Oct 29, 2026: Bambusa Therapeutics, Inc. filed Form S-1MEF with the SEC
Get BBTX news as it happens
Every headline, SEC filing and analyst action for BBTX on your live chart, with important news marked and alerts when it matters.
Try SEPT Free